Latest Content

An expert explained what patients newly diagnosed with gastrointestinal stromal tumors need to know.

Feeling like others have it worse can dismiss the real challenges of follicular lymphoma and leave patients without the support they need.

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.

Only 5% to 10% of breast cancers are caused by inherited gene mutations like BRCA1 or BRCA2. I do not carry one. But my family history was enough.

I love flowers, and I especially love the Japanese tradition of ikebana. In Japanese culture, ikebana is the art of flower arrangement.

Optimism, treatment momentum and communication gaps drive late systemic therapy, increasing hospitalization and intensive care use for patients with cancer.

The FDA approved Armlupeg as a biosimilar to Neulasta to reduce infection risk in people receiving chemotherapy and those exposed to radiation.

Meta: Stage 1 essential thrombocythemia is a chronic blood disorder with high platelets, manageable through monitoring, medication, lifestyle and care.

Breaking down what patients need to know about penile cancer, from diagnosis to treatment.

This guide explains diagnosis, staging, molecular testing and treatment options for non-small cell lung cancer to help patients prepare informed questions.

CURE sat down with Dr. Daniel J. Boffa to discuss the current treatment landscape of lung cancer care in recognition of Lung Cancer Awareness Month.

Dr. Daniel J. Boffa discusses advancements in lung cancer care, including the role of minimally invasive surgical techniques and new systemic therapies.